Compare VCEL & STGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | STGW |
|---|---|---|
| Founded | 1989 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1996 | 2006 |
| Metric | VCEL | STGW |
|---|---|---|
| Price | $32.58 | $5.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $58.50 | $8.39 |
| AVG Volume (30 Days) | 468.7K | ★ 1.8M |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | $276,259,000.00 | ★ $2,909,000,000.00 |
| Revenue This Year | $19.09 | $14.09 |
| Revenue Next Year | $17.96 | $2.59 |
| P/E Ratio | $101.67 | ★ N/A |
| Revenue Growth | ★ 16.45 | 2.39 |
| 52 Week Low | $29.24 | $4.03 |
| 52 Week High | $48.75 | $7.17 |
| Indicator | VCEL | STGW |
|---|---|---|
| Relative Strength Index (RSI) | 36.26 | 63.29 |
| Support Level | $31.34 | $4.94 |
| Resistance Level | $38.48 | $7.02 |
| Average True Range (ATR) | 1.42 | 0.33 |
| MACD | -0.31 | 0.17 |
| Stochastic Oscillator | 20.52 | 76.98 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.